Search results
'Extraordinary' study results offer new hope for advanced lung cancer patients being treated with...
USA TODAY via Yahoo News· 2 years agoPatients with advanced lung cancer had a better chance at survival when their treatment combined...
US FDA approves Bristol-Myers' lung cancer drug
Reuters via AOL· 6 months agoThe drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other...
FDA approves new Bristol Myers drug for lung cancer
BioPharma Dive via Yahoo Finance· 6 months agoAcquired via a $4 billion biotech buyout, Augtyro is one of an array of new products the pharma hopes will offset patent expirations for current top...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Stages of Lung Cancer Listed by Type
Verywell Health via Yahoo News· 5 months agoWith an Explanation of Symptom ProgressionMedically reviewed by Reza Samad, MD The stages of lung cancer range from 0 to 4 based on how advanced the...
Bristol Myers' (BMY) Opdivo Label Expansion Filings Get Accepted
Zacks via Yahoo Finance· 3 months agoBristol Myers (BMY) announces the acceptance of its regulatory filings for the perioperative Opdivo...
Keytruda gains first approval for pre- and post-surgery use in lung cancer
BioPharma Dive via Yahoo Finance· 7 months agoThe Merck drug leads competitors Opdivo and Imfinzi into a new immunotherapy setting, which aims to...
Bristol Myers' Opdivo extends survival in bladder cancer study
Reuters via AOL· 10 months agoThe drug met the dual main goals of extending overall survival and helping patients live without...
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) Opdivo, in combination with chemotherapy, gains European Commission approval...
This Drug Candidate Could Be a Winner for Bristol Myers
Motley Fool· 11 months agoLast month, Bristol Myers Squibb (NYSE: BMY) shared that its locally advanced or metastatic...
